TC BioPharm (TCBP) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The development of TC Biopharm (TCBP) relies on successful trial phases of cell-based therapies, while cash reserves for testing remain sufficient. The technology stack is based on automated bioreactors that eliminate manual labor in T-cell cultivation. This chart of the share price, with an EV/EBITDA ratio of , is available below. The operating model involves outsourcing production and research to third-party contractors to minimize capital expenditures.
tcbiopharm.com - analytical breakdowns and key metrics (TCBP)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
TCBP - Final Profit|Projected Future Earnings TC Biopharm|TCBP - Price to Earnings Ratio|Forward P/E Multiple TC Biopharm|TCBP - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|TCBP - Profit before interest, taxes and amortization|Earnings per share for the last twelve months TC BioPharm|TCBP - Earnings per one share for the last 12 months|Quarterly EPS earnings growth tcbiopharm.com|TCBP - Earnings per share increase in current year|Earnings growth forecast for next year TC Biopharm
Initial company analysis:TC BioPharm (Holdings) PLC (TCBP)
The ratio correlates the total enterprise value, including net debt, with operating profit before taxes and amortization, measuring the payback period of assets. This metric allows for the identification of company undervaluation by excluding the impact of debt load and tax regimes. For TC Biopharm (TCBP), logistics disruptions and sanctions are hindering drug development, which is reflected in the business's EV/EBITDA history as a risk of stagnating cash flows.
Competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|VERA: Enterprise Value to EBITDA Ratio|Dianthus Corp - Enterprise Value to Operating Income Before Depreciation Ratio|PHVS: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio AbCellera|Enterprise Value to EBITDA Ratio TRML|PGEN: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple PHAR|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NKTR (Nektar Corp)|EV/EBITDA Multiple UPB (Upstream Bio Inc)|Total Company Value to Operating Income Before Depreciation Ratio zenasbio.com (ZBIO)|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Gossamer Bio Inc|KalVista Pharmaceuticals Inc (KALV) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|SVRA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple RIGL|EV/EBITDA Multiple AnaptysBio Inc (ANAB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Astria Pharma ATXS|Business Value to Operating Income Before Depreciation ENGN|RAPT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Aerovate Therapeutics Inc (JBIO) - Enterprise Value to EBITDA Ratio|ACRS (Aclaris Therapeutics, Inc.) - Enterprise Value to EBITDA Ratio|KYTX: Enterprise Value to Operating Income Before Depreciation Ratio|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cabaletta Bio Inc (CABA)|EV/EBITDA Multiple VTYX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization THTX (theratech.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|ELDN (Eledon Pharmaceuticals Inc.) - Company Value to Operating Income Before Depreciation Ratio|AGEN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio CLYM|ZURA: EV/EBITDA Multiple|atyrpharma.com - Business Value to Operating Income Before Depreciation|ADAG (Adagene Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple Ikena Oncology, Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Shattuck Labs, Inc. (STTK)|EQ (equilliumbio.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Connect Biopharma Holdings Limited CNTB|IMUX - Enterprise Value to EBITDA Ratio|Atara Biotherapeutics Inc - EV/EBITDA Multiple|IFRX - EV/EBITDA Multiple|XFOR (X4 Pharma) - Enterprise Value to EBITDA Ratio|Adicet Bio, Inc. - Business Value to Operating Income Before Depreciation|CELU (Celularity Inc) - EV/EBITDA Multiple|inmunebio.com (INMB) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Barinthus Biotherapeutics plc (BRNS)|Enterprise Value to EBITDA Ratio Kezar Life Sciences Inc. KZR|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SAB Biotherapeutics, Inc SABS|AKTX - Enterprise Value to EBITDA Ratio|ENLV: Enterprise Value to EBITDA Ratio|QTTB - EV/EBITDA Multiple|GeoVax (GOVX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation EDSA|IBIO (iBio Corp) - EV/EBITDA Multiple|Company Value to EBITDA Carisma Tx CARM|Enterprise Value to EBITDA Ratio XTLB (XTL Biopharmaceuticals)|Enterprise Value to Operating Income Before Depreciation Ratio BOLT|EV/EBITDA Multiple HCWB (HCW Biologics)|APVO - Enterprise Value to EBITDA Ratio|AIM: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ADTX (Aditxt)|GRI: EV/EBITDA Multiple|XRTX (xortx.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HIND (Vyome Holdings) - EV/EBITDA Multiple|Revelation Biosciences Inc (REVB) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Indaptus (INDP)|SCNI - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CalciMedica CALI|AFMD (Affimed NV) - Company Value to Operating Income Before Depreciation Ratio|Allakos Therapeutics - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation HOOK (HOOKIPA Pharma Inc.)|IGMS: EV/EBITDA Multiple|iTeos Pharma (ITOS) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ocean Biomedical, Inc.|THRD: Business Value to Operating Income Before Depreciation
